HEALTH CARE SECTOR

BIOTECHNOLOGY INDUSTRY

BIIB

biogen idec inc (BIIB:NASDAQ GS)

Last $231.66 USD

Change Today -0.96 / -0.41%

Volume 286.2K

BIIB On Other Exchanges

Symbol

Exchange

BIIB:US

NASDAQ GS

IDP:GR

Frankfurt

As of 11:01 AM 05/24/13 All times are local (Market data is delayed by at least 15 minutes).

Earnings & Estimates Summary - BIOGEN IDEC INC (BIIB)

Biogen Idec Inc. to Report Q1, 2013 on Apr 25, 2013

CapIQ 04/25/2013 1:00 PM ET

Biogen Idec Inc. to Report Q4, 2012 on Jan 28, 2013

CapIQ 04/25/2013 1:00 PM ET

Biogen Idec Inc. to Report Q3, 2012 on Oct 25, 2012

CapIQ 04/25/2013 1:00 PM ET

2012 revenues at Biogen Idec Inc. totaled $5.5B USD, while annual earnings equaled $6.53 per share.

Quarterly Earnings & Estimates - BIOGEN IDEC INC (BIIB)

Actuals vs. Estimates for BIOGEN IDEC INC BIIB

Biogen Idec Inc.'s Quarterly Earnings

Biogen Idec Inc. reported 1st quarter 2013 earnings of $1.97 per share on 04/27/2013.

Annual Earnings & Estimates - BIOGEN IDEC INC (BIIB)

Biogen Idec Inc.'s Annual Earnings

Biogen Idec Inc. reported annual 2012 earnings of $6.53 per share on 01/30/2013.

Quarterly Revenues - BIOGEN IDEC INC (BIIB)

Biogen Idec Inc.'s Quarterly Revenues

Biogen Idec Inc. had 1st quarter 2013 revenues of $1.4B USD. This bettered the $1.4B USD consensus of the 21 analysts covering the company. This was 9.5% above the prior year's 1st quarter results.

Annual Revenues - BIOGEN IDEC INC (BIIB)

Biogen Idec Inc.'s Annual Revenues

Biogen Idec Inc. had revenues for the full year 2012 of $5.5B USD. This was 9.3% above the prior year's results.

Report Data Issue

Stock Quotes

Market data is delayed at least 15 minutes.

Recently Viewed
BIIB:US	$231.93 USD	-0.69

BIIB Competitors

Market data is delayed at least 15 minutes.

Company	Last	Change
Astellas Pharma Inc	¥5,410 JPY	-70.00
Becton Dickinson and Co	$99.77 USD	-0.40
Celgene Corp	$121.90 USD	-1.74
Regeneron Pharmaceuticals Inc	$248.50 USD	-6.37
Shire PLC	2,165 GBp	+31.00
View Industry Companies